1887

Abstract

SUMMARY

The tryptophan content of hepatitis B surface antigen (HBAg) was studied by spectrophotometric titration with -bromosuccinimide (NBS) at pH 4.0 in 8.0 -urea. A tryptophan value of 13.9 % or 22.4 residues/mol (mol. wt. = 30000) was obtained by this method. This value coupled with 2.3 mol per cent tyrosine content obtained by amino acid composition studies accounts for the unusually high extinction coefficient of HBAg (at 280 nm = 37.26). The modification of tryptophan residues with NBS did not cause cleavage of the protein or loss of biologic activity as determined by radioimmunoassay.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-24-3-571
1974-09-01
2024-04-27
Loading full text...

Full text loading...

/deliver/fulltext/jgv/24/3/JV0240030571.html?itemId=/content/journal/jgv/10.1099/0022-1317-24-3-571&mimeType=html&fmt=ahah

References

  1. Blumberg B. S., Alter H. J., Visnich S. 1965; A ‘new’ antigen in leukemia sera. Journal of American Medical Association 191:541–546
    [Google Scholar]
  2. Gaitonde M. K., Dorey T. 1970; A rapid and direct method for the quantitative determination of tryptophan in the intact protein. Biochemical Journal 117:907–911
    [Google Scholar]
  3. Gerin J. L., Vyas G. N. 1972; Hepatitis associated (Australia) antigen (HBAg): biophysical and immunochemical characteristics. In Progress in Transfusion and Transplantation pp 167–187 Edited by Schmidt P. J., Washington D.C. American Association of Blood Banks;
    [Google Scholar]
  4. Kim C., Bissel D. 1971; Stability of the lipid and protein of hepatitis associated (Australia) antigen. Journal of Infectious Diseases 123:470–476
    [Google Scholar]
  5. Krugman S., Giles J. P. 1972; The natural history of viral hepatitis. Canadian Medical Association Journal 106:442–446
    [Google Scholar]
  6. Millman I., Loeb L., Bayer M. 1970; Australia antigen (A hepatitis associated antigen). Purification and physical properties. Journal of Experimental Medicine 131:1190–1199
    [Google Scholar]
  7. Nomenclature of antigens associated with viral hepatitis type B. Center for disease control 1970 Morbidity and Mortality Weekly Report 23:29 1974
    [Google Scholar]
  8. Patchornik A., Lawson W. B., Witkop B. 1958; Selective cleavage of the peptide bonds. II. The tryptophyl peptide bond and the cleavage of glucagon. Journal of American Chemical Society 80:4747–4748
    [Google Scholar]
  9. Shulman N. R. 1970; Hepatitis associated antigen. American Journal of Medicine 49:669–692
    [Google Scholar]
  10. Spande T. F., Witkop B. 1967; Determination of the tryptophan content of proteins with A-bromosuccinimide. In Methods in Enzymology vol 8 pp 498–505 Edited by Colowick S. P., Kaplan N. O. New York: Academic Press Inc;
    [Google Scholar]
  11. Vyas G. N., Rao K. R., Ibrahim A. B. 1972; Australia antigen (hepatitis B antigen): A conformational antigen dependent on disulfide bonds. Science, New York 178:1300–1301
    [Google Scholar]
  12. Vyas G. N., Williams E. W., Klaus G. G. B., Bond H. E. 1972; Hepatitis associated Australia antigen. Protein, peptides and amino acid composition of the purified antigen with its use in determining sensitivity of the hemagglutination test. Journal of Immunology 108:1114–1118
    [Google Scholar]
  13. Zuckerman A. J. 1972; Laboratory investigation into the aetiology of human viral hepatitis. British Medical Bulletin 28:134–137
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-24-3-571
Loading
/content/journal/jgv/10.1099/0022-1317-24-3-571
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error